Harbor Capital Advisors’s Sage Therapeutics SAGE Stock Holding History

Harbor Capital Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-42,339	Closed	-$230K	–	1521
2024 Q4	$230K	Sell	42,339 -3,399	-7%	-$20.8K	0.01%	641
2024 Q3	$330K	Buy	45,738 +8,166	+22%	+$74.8K	0.01%	625
2024 Q2	$408K	Buy	37,572 +11,409	+44%	+$146K	0.03%	565
2024 Q1	$490K	Sell	26,163 -2,322	-8%	-$53.6K	0.06%	399
2023 Q4	$617K	Sell	28,485 -6,288	-18%	-$125K	0.12%	211
2023 Q3	$716K	Buy	34,773 +13,720	+65%	+$396K	0.15%	168
2023 Q2	$990K	Buy	+21,053	New	+$1.05M	0.2%	131

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return